Implanet SA - Asset Resilience Ratio
Implanet SA (ALIMP) has an Asset Resilience Ratio of 0.55% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Implanet SA (ALIMP) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2020)
This chart shows how Implanet SA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Implanet SA.
Liquid Assets Composition Over Time
This chart breaks down Implanet SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore ALIMP long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €93.00K | 0.55% |
| Total Liquid Assets | €93.00K | 0.55% |
Asset Resilience Insights
- Limited Liquidity: Implanet SA maintains only 0.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Implanet SA Industry Peers by Asset Resilience Ratio
Compare Implanet SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Implanet SA (2013–2020)
The table below shows the annual Asset Resilience Ratio data for Implanet SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 1.47% | €128.00K ≈ $149.65K |
€8.70 Million ≈ $10.17 Million |
+0.66pp |
| 2019-12-31 | 0.81% | €78.00K ≈ $91.19K |
€9.65 Million ≈ $11.28 Million |
-2.88pp |
| 2018-12-31 | 3.68% | €326.00K ≈ $381.13K |
€8.85 Million ≈ $10.35 Million |
-4.31pp |
| 2017-12-31 | 7.99% | €1.00 Million ≈ $1.17 Million |
€12.56 Million ≈ $14.69 Million |
+5.01pp |
| 2016-12-31 | 2.98% | €490.74K ≈ $573.72K |
€16.46 Million ≈ $19.24 Million |
-29.61pp |
| 2015-12-31 | 32.59% | €5.31 Million ≈ $6.21 Million |
€16.29 Million ≈ $19.04 Million |
+30.47pp |
| 2014-12-31 | 2.12% | €308.12K ≈ $360.22K |
€14.55 Million ≈ $17.02 Million |
-6.25pp |
| 2013-12-31 | 8.36% | €2.00 Million ≈ $2.34 Million |
€23.92 Million ≈ $27.97 Million |
-- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-… Read more